Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLORAZEPATE Cause Electrocardiogram qt prolonged? 29 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Electrocardiogram qt prolonged have been filed in association with CLORAZEPATE (Clorazepate Dipotassium). This represents 1.6% of all adverse event reports for CLORAZEPATE.

29
Reports of Electrocardiogram qt prolonged with CLORAZEPATE
1.6%
of all CLORAZEPATE reports
2
Deaths
18
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From CLORAZEPATE?

Of the 29 reports, 2 (6.9%) resulted in death, 18 (62.1%) required hospitalization, and 12 (41.4%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLORAZEPATE. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does CLORAZEPATE Cause?

Coma (203) Toxicity to various agents (173) Somnolence (142) Off label use (109) Drug abuse (98) Hypotension (96) Intentional overdose (94) Drug ineffective (92) Fall (92) Anxiety (78)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which CLORAZEPATE Alternatives Have Lower Electrocardiogram qt prolonged Risk?

CLORAZEPATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN CLORAZEPATE vs CLOTHIAPINE CLORAZEPATE vs CLOTIAZEPAM CLORAZEPATE vs CLOTRIMAZOLE CLORAZEPATE vs CLOXACILLIN

Related Pages

CLORAZEPATE Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged CLORAZEPATE Demographics